FDA Clears IMRIS Visius Surgical Theatre Upgrade
IMRIS Inc.’s upgraded Visius Surgical Theatre integrates Siemens' high-field MR scanners.
The core imaging technology based on Siemens Aera 1.5T(tesla) and Skyra 3.0T technology helps IMRIS deliver better image quality with higher signal-to-noise ratio. It also provides faster 3-D image acquisition and improved ease-of-use and workflow during neurosurgical procedures using intraoperative MRI (iMRI).
Inside a Visius Surgical Theatre equipped with either high-field iMRI or iCT, surgeons have on-demand access to real-time data and imaging during the procedure from the OR table.
The U.S. Food and Drug Administration (FDA) cleared IMRIS Inc.’s upgraded Visius Surgical Theatre in February 2014.
For more information: www.imris.com